Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    9305658 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: pegylated interferon alpha-2b;   Drug: Ribavirin;   Drug: pegylated Interferon alpha-2b

Study has passed its completion date and status has not been verified in more than two years.